Ligand Pharmaceuticals Incorporated (LGND) Price Forecast — AI Targets | MarketCI

Ligand Pharmaceuticals Incorporated (LGND) Price Forecast — AI Targets | MarketCI | MarketCI

LGND

Market Closed

Ligand Pharmaceuticals Incorporated

NASDAQHealthcare Biotechnology

47 employees

CEO: Todd C. Davis

Founded: 1992

$300.95

+$0.00(+NaN%)

Market Cap

6.03B

Beta

0.98

52W Range

N/A

Dividend Yield

0.15%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Forecasting Analysis

AI-powered predictions and statistical risk modeling for short-term price movements

AI Insight:

Ligand Pharmaceuticals' AI forecast signals strong short-term positive momentum, trending higher significantly. Analyst consensus projects downside risk over 12 months with a tight, broadly aligned range, reflecting strong coverage. This divergence highlights heightened near-term opportunity against longer-term caution and risk exposure.

Current Price

N/A

Last closing price

Price Prediction

Machine learning prediction based on historical price patterns

Period:

Analyst Price Target for LGND

Loading analyst price targets...

Wall Street Forecasts

Revenue Forecast

Past Growth

N/A

Based on Historical CAGR

Forward Growth

N/A

Projected CAGR

Analyst Accuracy

Estimate Accuracy

Revenue Analysis

Comparison of Actual and Estimated Revenues

Loading chart data...

Revenue growth steady at 0.0%.

Operating Profitability Forecast

Past Growth

N/A

EBITDA Historical CAGR

Forward Growth

N/A

EBITDA Projected CAGR

Analyst Accuracy

Estimate Accuracy

EBITDA Analysis

Comparison of Actual and Estimated EBITDA

Loading chart data...

EBITDA maintaining 0.0% trajectory.

Earnings Per Share Forecast

Past Growth

N/A

EPS Historical CAGR

Forward Growth

N/A

EPS Projected CAGR

Analyst Accuracy

Estimate Accuracy

EPS Analysis

Comparison of Actual and Estimated Earnings Per Share

Loading chart data...

EPS growth stable around 0.0%.

Explore LGND

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

LGND in the Healthcare

Mid Cap

Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →